More about

Headache

News
April 27, 2023
2 min read
Save

Headache-related quality of life lagged in adults with long COVID

Headache-related quality of life lagged in adults with long COVID

BOSTON — Headache-related quality of life lagged clinical improvement in headaches for individuals with long COVID at 12 to 19 months, according to a poster from the American Academy of Neurology annual meeting.

News
April 27, 2023
2 min watch
Save

VIDEO: Ubrogepant may prevent headache when dosed in prodromal phase

VIDEO: Ubrogepant may prevent headache when dosed in prodromal phase

BOSTON — Fewer patients who took ubrogepant during the premonitory phase went on to have headache when compared with placebo, Peter Goadsby, MD, PhD, FRS, said in this Healio video at the American Academy of Neurology annual meeting.

News
March 06, 2023
1 min read
Save

Vistagen receives US patent for nasal spray to treat migraine

Vistagen receives US patent for nasal spray to treat migraine

Vistagen announced that the U.S. Patent and Trademark Office granted a patent for the company’s investigational pherine PH80 nasal spray for the treatment of migraine.

News
February 03, 2023
1 min read
Save

Vistagen completes acquisition of Pherin Pharmaceuticals

Vistagen completes acquisition of Pherin Pharmaceuticals

A California-based biopharmaceutical company has announced the completion of its acquisition of Pherin Pharmaceuticals Inc., a drug development firm that specializes in neuropsychiatric and neuroendocrine issues.

News
January 11, 2023
2 min read
Save

Migraine, severe headache history associated with hypertension risk

Migraine, severe headache history associated with hypertension risk

U.S. adults who reported a history of migraine or severe headache were 25% more likely to develop hypertension compared with those with no migraine history, with a higher risk for women vs. men, researchers reported.

News
November 08, 2022
1 min read
Save

Case study: COVID-19-induced hyposmia prevented migraines triggered by strong odors

Case study: COVID-19-induced hyposmia prevented migraines triggered by strong odors

CHICAGO — COVID-19-induced hyposmia eliminated odor-induced migraine headaches in an older adult, a case study presented at the 2022 American Neurological Association’s annual meeting showed.

News
October 28, 2022
2 min read
Save

Over 1.5 million US vets diagnosed with headache: improved outreach, care needed

Over 1.5 million US vets diagnosed with headache: improved outreach, care needed

CHICAGO — With more than 1.5 million veterans diagnosed with headache over the past two decades, the Veterans Health Administration must improve outreach and care to address disparities, an expert said at ANA 2022.

News
October 19, 2022
3 min read
Save

Evaluate headache characteristics to classify as migraine

Evaluate headache characteristics to classify as migraine

LAS VEGAS — Certain red flags can indicate that a patient’s headaches are the migraine type, Merle Diamond, MD, said at PAINWeek 2022.

News
October 18, 2022
1 min read
Save

Theranica announces positive results from clinical trial for migraine treatment device

Theranica announces positive results from clinical trial for migraine treatment device

Theranica Bio-electronics announced positive top-line results from a double-blind, randomized, placebo-controlled, multicenter clinical trial to evaluate efficacy and safety of Nerivio for the treatment of episodic and chronic migraine.

News
September 12, 2022
2 min read
Save

Obefazimod bests placebo, improves ulcerative colitis in phase 2b induction trial

Obefazimod bests placebo, improves ulcerative colitis in phase 2b induction trial

Obefazimod improved moderate to severe ulcerative colitis compared with placebo in patients with documented nonresponse or intolerance to previous treatment, according to new data published in The Lancet Gastroenterology & Hepatology.

View more